Sandy Mercurio

Pediatric brain tumors,fluvastatin/celecoxib,drug repositioning,pilocytic astrocytoma,molecular profil,BRAF

Dominique Figarella-Branger	grad student	2013	Aix-Marseille University
(Mise en évidence de nouvelles cibles thérapeutiques dans les tumeurs gliales et glioneuronales de l'enfant)

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Denicolaï E, Baeza-Kallee N, Tchoghandjian A, et al. (2014) Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo. Oncotarget. 5: 10934-48
Mercurio S, Padovani L, Colin C, et al. (2013) Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma. Acta Neuropathologica Communications. 1: 17
Figarella-Branger D, Chappe C, Padovani L, et al. (2013) [Glial and glioneuronal tumors in adults and children: main genetic alterations and towards a histomolecular classification]. Bulletin Du Cancer. 100: 715-26
Chappé C, Padovani L, Scavarda D, et al. (2013) Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Brain Pathology (Zurich, Switzerland). 23: 574-83
Colin C, Padovani L, Chappé C, et al. (2013) Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution. Neuropathology and Applied Neurobiology. 39: 693-705
Padovani L, Colin C, Fernandez C, et al. (2012) Search for distinctive markers in DNT and cortical grade II glioma in children: same clinicopathological and molecular entities? Current Topics in Medicinal Chemistry. 12: 1683-92